Seizing Entrepreneurial Opportunities in Pudong: Embracing the Rise of Returnee Entrepreneurs
From November 9th to 11th, under the guidance of the United Front Work Department of the Shanghai Municipal Committee (Overseas Chinese Affairs Office of the Municipal Government), the “Overseas Chinese Innovation and Entrepreneurship Study Camp” (the 3rd Study Camp for Overseas Chinese Young Science and Technology Entrepreneurs and the 16th Study Camp for Overseas Chinese Returnees’ Entrepreneurship) was hosted by the United Front Work Department of the Pudong New Area Committee (Overseas Chinese Affairs Office of the District Government) and commenced in Zhangjiang. Focusing on the trend of overseas talent “returning” to China, the event aims to provide a platform for nurturing and fostering the innovation and entrepreneurship of young people in the overseas Chinese community who come to Shanghai, further strengthen exchanges with the new generation of overseas Chinese, and cultivate their patriotism and love for their hometown.
Meanwhile, Shanghai Television’s program “632 Observations” also conducted an interview with Kayla Yuan, a director at HB Ventures, to explore together the new opportunities being discovered by young overseas Chinese science and technology entrepreneurs.
Related Posts
” E-Tronic(Guangzhou) Technology” completes Series A financing led by Infinity Capital
E-Tronic(Guangzhou)Technology Co.，Ltd., a provider of power semiconductors and system solutions for new energy vehicles, has completed its Series A financing with a cumulative amount of over 100 million RMB. This round of financing was led by Infinity Capital, with additional investment from old shareholders Zhongnan Venture Capital and Guangzhou Development
Leto Laboratories Completes Series C Financing of Over 100 Million RMB, Focusing on 0 to 1 Innovative Protein Design and Manufacturing Platform Construction
Leto Laboratories announced the completion of its Series C financing round with a funding size of over 100 million RMB. This round of financing was led by Zhongguancun Science City Corporation and followed by Infiniti Capital and HB Ventures. The round was mainly used for the clinical research of LTC004, a new-generation anti-tumor cytokine class […]
Pillar Biosciences Closes $29.7 Million in Series C Financing
May 12, 2020NGS clinical cancer diagnostics company Pillar Biosciences held a Series C financing signing ceremony at its headquarters in Boston, USA, officially announcing the completion of a $29.7 million Series C financing round led by ORI Healthcare Fund, which raised Series A funding. The financing will accelerate the expansion of Pillar’s R&D pro
Changyi Wins Industrial Excellence Award in Weixin Pay Application Competition
iClick Interactive Asia Group Limited (“iClick” or the “Company”), an independent online marketing and enterprise data solutions provider in China, announced that Changyi (Shanghai) Information Technology Co., Ltd (“Changyi”), a subsidiary of iClick, has been awarded a major industry accolade by Tencent’s Weixin Pay for its outstanding s